These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30810383)

  • 1. HybridPower: An R Package for a Bayesian-Frequentist Hybrid Approach to Power Analysis.
    Park J; Pek J
    Multivariate Behav Res; 2019; 54(1):151-152. PubMed ID: 30810383
    [No Abstract]   [Full Text] [Related]  

  • 2. Conducting Bayesian-Classical Hybrid Power Analysis with R Package Hybridpower.
    Park J; Pek J
    Multivariate Behav Res; 2023; 58(3):543-559. PubMed ID: 35263213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Bayesian Power Analysis Procedure Considering Uncertainty in Effect Size Estimates from a Meta-analysis.
    Du H; Wang L
    Multivariate Behav Res; 2016; 51(5):589-605. PubMed ID: 27485763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BioBayes: a software package for Bayesian inference in systems biology.
    Vyshemirsky V; Girolami M
    Bioinformatics; 2008 Sep; 24(17):1933-4. PubMed ID: 18632751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complexities in power analysis: Quantifying uncertainties with a Bayesian-classical hybrid approach.
    Pek J; Park J
    Psychol Methods; 2019 Oct; 24(5):590-605. PubMed ID: 30816728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian perspectives for epidemiological research: I. Foundations and basic methods.
    Greenland S
    Int J Epidemiol; 2006 Jun; 35(3):765-75. PubMed ID: 16446352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moving in Parallel Toward a Modern Modeling Epistemology: Bayes Factors and Frequentist Modeling Methods.
    Rodgers JL
    Multivariate Behav Res; 2016; 51(1):30-4. PubMed ID: 26881955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian perspectives for epidemiological research. II. Regression analysis.
    Greenland S
    Int J Epidemiol; 2007 Feb; 36(1):195-202. PubMed ID: 17329317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian designs and the control of frequentist characteristics: a practical solution.
    Ventz S; Trippa L
    Biometrics; 2015 Mar; 71(1):218-226. PubMed ID: 25196832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comments on Bayesian and frequentist analysis and interpretation of clinical trials.
    Fisher LD
    Control Clin Trials; 1996 Oct; 17(5):423-34. PubMed ID: 8932975
    [No Abstract]   [Full Text] [Related]  

  • 11. The Bayesian New Statistics: Hypothesis testing, estimation, meta-analysis, and power analysis from a Bayesian perspective.
    Kruschke JK; Liddell TM
    Psychon Bull Rev; 2018 Feb; 25(1):178-206. PubMed ID: 28176294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian approach for quantifying the uncertainty of neutron doses derived from spectrometric measurements.
    Reginatto M
    Radiat Prot Dosimetry; 2006; 121(1):64-9. PubMed ID: 16877470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A case for Bayesianism in clinical trials.
    Berry DA
    Stat Med; 1993 Aug; 12(15-16):1377-93; discussion 1395-404. PubMed ID: 8248653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Joining forces of Bayesian and frequentist methodology: a study for inference in the presence of non-identifiability.
    Raue A; Kreutz C; Theis FJ; Timmer J
    Philos Trans A Math Phys Eng Sci; 2013 Feb; 371(1984):20110544. PubMed ID: 23277602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of parameter uncertainty for an activated sludge model using Bayesian inference: a comparison with the frequentist method.
    Zonta ZJ; Flotats X; Magrí A
    Environ Technol; 2014 Aug; 35(13-16):1618-29. PubMed ID: 24956752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Bayesian-frequentist two-stage single-arm phase II clinical trial design.
    Dong G; Shih WJ; Moore D; Quan H; Marcella S
    Stat Med; 2012 Aug; 31(19):2055-67. PubMed ID: 22415966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparing Bayesian and frequentist approaches for multiple outcome mixed treatment comparisons.
    Hong H; Carlin BP; Shamliyan TA; Wyman JF; Ramakrishnan R; Sainfort F; Kane RL
    Med Decis Making; 2013 Jul; 33(5):702-14. PubMed ID: 23549384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Bayesian approach to stochastic cost-effectiveness analysis.
    Briggs AH
    Health Econ; 1999 May; 8(3):257-61. PubMed ID: 10348420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian predictive approach to interim monitoring in clinical trials.
    Dmitrienko A; Wang MD
    Stat Med; 2006 Jul; 25(13):2178-95. PubMed ID: 16007570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian evaluation of informative hypotheses in cluster-randomized trials.
    Moerbeek M
    Behav Res Methods; 2019 Feb; 51(1):126-137. PubMed ID: 30350025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.